
Incanthera plc (INC.AQ)
- Previous close
1.9950 - Open
2.2000 - Bid --
- Ask --
- Day's range
1.5001 - 2.2000 - 52-week range
0.0050 - 2.2750 - Volume
434,598 - Avg. Volume
227,399 - Market cap (intra-day)
2.069M - Beta (5Y monthly) 0.62
- PE ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings date (est.) --
- Forward dividend & yield --
- Ex-dividend date --
- 1y target est
--
Incanthera plc, a dermatology and oncology therapeutics company, engages in the dermatological formulation and delivery technologies for various indications. The company develops skincare products under the Skin + CELL brand name. Incanthera plc was founded in 2010 and is headquartered in Manchester, the United Kingdom.
www.incanthera.com8
Full-time employees
31 March
Fiscal year ends
Healthcare
Sector
Biotechnology
Industry
Recent news
View morePerformance overview
Trailing total returns as of 14/07/2026, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD return
1-year return
3-year return
5-year return
Statistics
View moreValuation measures
Market cap
2.41M
Enterprise value
2.20M
Trailing P/E
--
Forward P/E
--
PEG ratio (5-yr expected)
--
Price/sales (ttm)
358.72
Price/book (mrq)
3.19
Enterprise value/revenue
366.49
Enterprise value/EBITDA
--
Financial highlights
Profitability and income statement
Profit margin
0.00%
Return on assets (ttm)
-66.85%
Return on equity (ttm)
-170.49%
Revenue (ttm)
6k
Net income avi to common (ttm)
-2.27M
Diluted EPS (ttm)
-0.0200
Balance sheet and cash flow
Total cash (mrq)
215k
Total debt/equity (mrq)
--
Levered free cash flow (ttm)
-850.75k
Compare
Select to analyse similar companies using key performance metrics; select up to four stocks.

